Hepatitis C virus: The nephrologist's view

American Journal of Kidney Diseases

Volumn 25, Issue 1, 1995, Pages 3-16

  Roth, David ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

cryoglobulinemia; dialysis; glomerulonephritis; Hepatitis C virus; transplantation

Indexed keywords

ALPHA2B INTERFERON; AMINOTRANSFERASE; HEPATITIS C ANTIBODY; VIRUS RNA;

ANTIGEN ANTIBODY COMPLEX; BLOOD TRANSFUSION; CRYOGLOBULINEMIA; ENZYME LINKED IMMUNOSORBENT ASSAY; HEMODIALYSIS; HEPATITIS B; HEPATITIS C; HEPATITIS C VIRUS; HEPATITIS NON A NON B; HUMAN; IMMUNE COMPLEX NEPHRITIS; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; MEMBRANOUS GLOMERULONEPHRITIS; POLYMERASE CHAIN REACTION; PROTEINURIA; REVIEW; VIREMIA;

CRYOGLOBULINEMIA; GLOMERULONEPHRITIS; HEPACIVIRUS; HEPATITIS C; HUMAN; KIDNEY FAILURE, CHRONIC;

EID: 0028870340     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1016/0272-6386(95)90617-7     Document Type: Review

References (87)

1. Hepatitis C virus infection in post-transfusion hepatitis: An analysis with first and second-generation assays
2. Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis
3. Molecular biology of the hepatitis C viruses: Implications for diagnosis, development and control of viral disease
4. Detection of hepatitis C viral sequences in blood donations by “nested” polymerase chain reaction and prediction of infectivity
5. Detection of serum hepatitis C virus RNA in HCV antibody-seropositive volunteer blood donors
6. Hepatitis C infection in two urban hemodialysis units
7. The prevalence of hepatitis C virus antibodies among hemodialysis patients
8. Prevalence of hepatitis C virus infection in hemodialysis patients: A longitudinal study comparing the results of RNA and antibody assays
9. Hepatitis virus infection (HBV and HCV) in eleven Japanese hemodialysis units
10. Risk factors for dialysis-associated hepatitis C in Venezuela
11. High prevalence of antibodies to hepatitis C virus in hemodialysis units using a second generation assay
12. Antibodies to hepatitis C virus by second generation test in hemodialysed patients
13. Comparison between first and second generation tests to determine the frequency of anti-HCV antibodies in uremic patients in replacement dialytic therapy
14. Hepatitis C infection among dialysis patients: A comparison between patients on maintenance hemodialysis and continuous ambulatory peritoneal dialysis
15. Prevalence of HCV antibodies in a uremic population undergoing maintenance dialysis therapy and in the staff members of the dialysis unit
16. The prevalence of hepatitis C virus antibodies in patients treated with continuous ambulatory peritoneal dialysis
17. The need for second generation anti-hepatitis C virus testing in uremic patients on continuous ambulatory peritoneal dialysis
18. Hepatitis C virus RNA in anti-HCV positive hemodialysis patients: significance and therapeutic implications
19. Detection of hepatitis C infection by polymerase chain reaction among hemodialysis patients
20. Detection of hepatitis C virus RNA in hemodialysis patients
21. Hepatitis C in dialysis patients: relationship to blood transfusions, dialysis and liver disease
22. Hepatitis C infection in a pediatric dialysis population
23. Prevalence of hepatitis C virus antibodies in hemodialysis patients and dialysis staff
24. Multicenter study of hepatitis C virus infection in chronic hemodialysis patients and hemodialysis center staff members
25. Antibody to hepatitis C virus increases with time on hemodialysis
26. Hepatitis C virus antibodies in hemodialysis patients
27. National surveillance of hemodialysis associated diseases in the United States, 1990
28. Prevalence of antibodies against hepatitis C virus in a dialysis unit
29. Prevalence of antibodies to hepatitis C virus in the hemodialysis unit
30. Outbreak of hemodialysis-associated non-A, non-B hepatitis and correlation with antibody to hepatitis C virus
31. Prevalence of hepatitis C virus antibodies in hospital personnel
32. Low risk of health care workers for infection with hepatitis C virus
33. Antibody to hepatitis B core antigen as a paradoxical marker for non-A, non-B hepatitis agents in donated blood
34. The declining risk of post-transfusion hepatitis C virus infection
35. Low aspartate transaminase activity in serum of patients undergoing chronic hemodialysis
36. Liver disease patterns in hemodialysis patients with antibodies to hepatitis C virus
37. Late seroconversion of C virus markers in hemodialysis patients
38. Role of hepatitis C virus infection in spontaneous hepatitis B surface antigen clearance during chronic hepatitis B virus infection
39. Behavior of antibody profile against hepatitis C virus in patients on maintenance hemodialysis
40. Non-A, non-B hepatitis: A prospective study of a hemodialysis outbreak with evaluation of a serologic marker in patients and staff
41. Outbreak of non-A, non-B hepatitis in hemodialysis patients: A retrospective analysis
42. Incidence and risk factors for hepatitis C sero-conversion in hemodialysis
43. Strategies to reduce the transmission of HCV infection in hemodialysis units
44. Dialysis-associated infections and their control
45. Treatment of hemodialysis patients suffering from chronic HCV-infection with interferon alpha
46. Chronic hepatitis in end-stage renal disease: Comparison of HBsAg-negative and HBsAg-positive patients
47. Liver disease in recipients of long-functioning renal allografts
48. Non hepatitis B-associated liver disease in a renal transplant population
49. Impact of hepatitis on renal transplantation
50. Clinical implications of the presence of antibodies to hepatitis C after renal transplantation
51. Hepatitis C virus in kidney recipients: Epidemiology and impact on renal transplantation
52. Transmission of hepatitis C virus by organ transplantation
53. Detection of hepatitis C virus infection among cadaver organ donors: Evidence for low transmission of disease
54. National Collaborative study of anti-HCV in cadaver donors: Reduced organ wastage using a second generation anti-HCV test
55. Prevalence of hepatitis C virus RNA in organ donors positive for hepatitis C antibody and in the recipients of their organs
56. Depletion of hepatitis C virus from procured kidneys using pulsatile perfusion preservation
57. Detection of antibody to hepatitis C virus in renal transplant recipients
58. The impact of hepatitis C virus infection on renal allograft recipients
59. Hepatitis C virus infection among kidney transplant recipients
60. Hepatitis C virus antibodies in patients after kidney transplantation
61. Hepatitis C antibody in renal transplant patients
62. Hepatitis C—Its prevalence in end-stage renal failure patients and clinical course after kidney transplantation
63. A prospective study of hepatitis C infection among renal transplant recipients
64. The clinical outcome of hepatitis C virus antibody-positive renal allograft recipients
65. Value of liver biopsy in the evaluation and management of chronic liver disease in renal transplant recipients
66. Structure and organization of the hepatitis C virus genome isolated from human carriers
67. A high prevalence of antibody to hepatitis C virus in patients with hepatocellular carcinoma in Japan
68. Clinical study of hepatitis disorders in renal transplant recipients with special reference to hepatitis C
69. Hepatitis C in renal transplant recipients
70. Cellular immune response to cytomegalovirus infection after renal transplantation
71. Assessment of the status of cell mediated immunity in cytomegalovirus infected renal allograft recipients
72. Cytomegalovirus infection—An etiological factor for rejection?
73. Hepatitis C virus infection and membranous glomerulonephritis
74. Membranous glomerulonephritis in association with hepatitis C virus infection
75. Membranoproliferative glomerulonephritis associated with hepatitis C virus infection
76. Membranoproliferative glomerulonephritis type I associated with chronic hepatitis C virus infection
77. Membranoproliferative glomerulonephritis associated with hepatitis C virus infection
78. Renal involvement in essential mixed cryoglobulinemia
79. A role for hepatitis C virus infection in type II cryoglobulinemia
80. Hepatitis C virus infection in patients with essential mixed cryoglobulinemia
81. Cryoglobulinemia and hepatitis C infection
82. Antibodies to hepatitis C virus in essential mixed cryoglobulinemia
83. Hepatitis C virus and mixed cryoglobulinemias
84. Antibodies to hepatitis C virus in patients with mixed cryoglobulinemia
85. Hepatitis C A possible etiology for cryoglobulinemia type II
86. Treatment of idiopathic mixed cryoglobulinemia with alpha interferon
87. Effect of interferon-α 2b on cryoglobulinemia related to hepatitis C virus infection